Volastra Therapeutics

Volastra Therapeutics

Volastra Therapeutics

Volastra aims to extend the lives of patients with cancer by leveraging unique insights into chromosomal instability (CIN). By focusing on CIN in the toughesttotreat solid tumors, we are altering the treatment paradigm for metastatic cancers.
Type
B2b
Raised
$12M
Follow us
Alexa global traffic share
Latest funding
Team Size
1–10
Employees
$12,000,000 Seed fund
FinSMEs

Volastra Therapeutics Raises $12M in Seed Financing